"Cell Line, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cell line derived from cultured tumor cells.
| Descriptor ID |
D045744
|
| MeSH Number(s) |
A11.251.210.190 A11.251.860.180
|
| Concept/Terms |
Cell Line, Tumor- Cell Line, Tumor
- Cell Lines, Tumor
- Line, Tumor Cell
- Lines, Tumor Cell
- Tumor Cell Lines
- Tumor Cell Line
|
Below are MeSH descriptors whose meaning is more general than "Cell Line, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Cell Line, Tumor".
This graph shows the total number of publications written about "Cell Line, Tumor" by people in this website by year, and whether "Cell Line, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 9 | 9 |
| 2004 | 0 | 20 | 20 |
| 2005 | 1 | 22 | 23 |
| 2006 | 0 | 29 | 29 |
| 2007 | 0 | 28 | 28 |
| 2008 | 0 | 39 | 39 |
| 2009 | 0 | 53 | 53 |
| 2010 | 0 | 40 | 40 |
| 2011 | 0 | 52 | 52 |
| 2012 | 0 | 27 | 27 |
| 2013 | 0 | 54 | 54 |
| 2014 | 1 | 38 | 39 |
| 2015 | 0 | 57 | 57 |
| 2016 | 0 | 60 | 60 |
| 2017 | 1 | 49 | 50 |
| 2018 | 0 | 50 | 50 |
| 2019 | 0 | 55 | 55 |
| 2020 | 0 | 45 | 45 |
| 2021 | 0 | 39 | 39 |
| 2022 | 0 | 21 | 21 |
| 2023 | 0 | 9 | 9 |
| 2024 | 0 | 26 | 26 |
| 2025 | 0 | 16 | 16 |
| 2026 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Line, Tumor" by people in Profiles.
-
Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth. Mol Cancer Ther. 2026 Feb 04; 25(2):257-271.
-
Nanoluciferase-CD63 labeling reveals extracellular vesicle kinetics in a mouse intraductal model of ductal carcinoma in situ. Breast Cancer Res. 2026 Jan 30; 28(1).
-
Identification and Experimental Validation of Triosephosphate Isomerase 1 as a Functional Biomarker of SHetA2 Sensitivity in Ovarian Cancer. Cells. 2026 Jan 30; 15(3).
-
Adaptation to cystine limitation stress confers a targetable lipid metabolism vulnerability in pancreatic ductal adenocarcinoma. Nat Commun. 2025 Dec 31; 17(1):1343.
-
A Fluorescence Resonance Energy Transfer-Based Assay Targeting Tumor-Derived Extracellular Vesicles for Highly Specific Pancreatic Cancer Detection. ACS Nano. 2025 Dec 23; 19(50):42056-42065.
-
A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growth. Sci Rep. 2025 Oct 14; 15(1):35811.
-
Enhancing mRNA therapy through iterative delivery. Sci Adv. 2025 Oct 03; 11(40):eadx0916.
-
Using MUC2 mucin producing tumorigenic human goblet-like cells to uncover functional properties of the mucus barrier. Gut Microbes. 2025 Dec; 17(1):2542385.
-
Exosome-Associated MTA1 in Circulation Is Elevated During Breast Cancer Progression. FASEB J. 2025 Jul 31; 39(14):e70872.
-
Novel fusion superkine, IL-24S/IL-15, enhances immunotherapy of brain cancer. J Immunother Cancer. 2025 Jun 22; 13(6).